NDC 16729-393 - amlodipine besylate and olmesartan medoxomil
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-393
- Package NDCs from labels
- 16729-393-10, 16729-393-15, 16729-393-16, 16729-393-17
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2019-08-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| POVIDONE K30 - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2019-08-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-393-10 | amlodipine besylate and olmesartan medoxomil | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 2 | |
| 16729-393-15 | amlodipine besylate and olmesartan medoxomil | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 2 | |
| 16729-393-16 | amlodipine besylate and olmesartan medoxomil | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 2 | |
| 16729-393-17 | amlodipine besylate and olmesartan medoxomil | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | f77db79c-c998-4b63-9984-4cf245f188a7 | 2023-09-10 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | d830173d-7676-4490-ab3d-d3515df9ad2e | 2023-09-07 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 5dfcba1f-91c4-4ca5-8a98-fc4fdb2f7ee1 | 2023-09-07 | Warnings, Adverse reactions | 864V2Q084H |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 15FIX9V2JP |
| Lipotox | SQUALENE, CHOLESTERINUM, ESTRADIOL, PROGESTERONE, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, | BioActive Nutritional, Inc. | a1538692-ca00-4e52-9b7e-409767ee27e1 | 2023-09-05 | Warnings | 15FIX9V2JP |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 15FIX9V2JP |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 15FIX9V2JP |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 949e6bad-fcb2-42f2-b9c8-e5620ef5ccd5 | 2023-08-28 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 69a887ab-95cd-4b81-80ee-02e20eebf65b | 2023-08-24 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Azor | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL | Cosette Pharmaceuticals, Inc. | c5535406-b63b-49aa-88b9-169aaf0ed08e | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 730872 730866 730861 730869 864V2Q084H 6M97XTV3HD |
| Benicar | OLMESARTAN MEDOXOMIL | Cosette Pharmaceuticals, Inc. | 5b6f8a18-8f8a-4521-81c3-3a39c73c6646 | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Benicar HCT | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | Cosette Pharmaceuticals, Inc. | 881a1c32-c209-4038-9c5e-c5e46c6e0546 | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Tribenzor | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Cosette Pharmaceuticals, Inc. | 2f56d0bc-236b-41a0-9fc0-21cdfea8d890 | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H 6M97XTV3HD |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Alembic Pharmaceuticals Inc. | cf4f62f9-5a00-4313-b703-ec0ac6380b5e | 2023-06-23 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Sheer Tint Mineral Sunscreen Broad Spectrum SPF 50 - Light/Medium Shade | SPF 50 SUNSCREEN BROAD SPECTRUM - LIGHT/MEDIUM SHADE | Autumn Harp | fd6807e1-c8c0-b361-e053-6294a90aea0c | 2023-06-05 | Warnings | 15FIX9V2JP |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 409e06ad-2ea9-4b47-829e-57139e22eac9 | 2023-06-05 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | ced6d26e-8c54-4808-88b6-446344f4acd0 | 2023-06-01 | Warnings, Adverse reactions | 864V2Q084H |
| Thinksport Mineral SPF 50 | ZINC OXIDE AND TITANIUM DIOXIDE | thinkOperations,LLC | 77b63c0b-353b-4f5f-95c7-6f7eeab81471 | 2023-05-30 | Warnings | 15FIX9V2JP |
| Think Kids Mineral SPF 50 | ZINC OXIDE AND TITANIUM DIOXIDE | thinkOperations,LLC | 25c59820-a08d-4abe-87ae-a787ac8b2ac2 | 2023-05-30 | Warnings | 15FIX9V2JP |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 7afa79de-d42e-4429-874d-449d47a59fbe | 2023-05-25 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.